Related Experiment Video
Updated: Aug 4, 2026

Utilization of the Soft Agar Colony Formation Assay to Identify Inhibitors of Tumorigenicity in Breast Cancer Cells
Published on: May 20, 2015
The ARF-B23 connection: implications for growth control and cancer treatment
1Department of Molecular and Cellular Oncology, University of Texas, MD Anderson Cancer Center, Houston, Texas 77030-4009, USA. ypzhang@mdanderson.org
Abstract:
The tumor suppressor ARF induces a p53-dependent and -independent cell cycle arrest. Unlike nucleoplasmic localized MDM2 and p53, ARF localizes in the nucleolus. The role of ARF in the nucleolus and the molecular target and mechanism of ARF's p53-independent function remain both controversial and a fertile field of research. Recent study has identified the nucleolar protein B23 as a target of ARF for implementing its growth inhibitory function. The ability of ARF to block cell cycle progression through the MDM2-p53 pathway and to suppress ribosomal biogenesis through B23 suggest a role for ARF in coordinating inhibitions of growth and proliferation.
Insights
The tumor suppressor ARF protein halts cell cycle progression through p53-dependent and -independent pathways. It also inhibits cell growth by targeting nucleolar protein B23, coordinating proliferation and growth suppression.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- The tumor suppressor ARF protein plays a critical role in cell cycle regulation.
- ARF exhibits both p53-dependent and p53-independent mechanisms for inducing cell cycle arrest.
- ARF's localization in the nucleolus and its p53-independent functions are areas of ongoing research.
Purpose of the Study:
- To investigate the molecular target and mechanism of ARF's p53-independent function.
- To elucidate ARF's role in the nucleolus and its impact on cell growth.
- To understand how ARF coordinates cell growth and proliferation inhibition.
Main Methods:
- The study identified the nucleolar protein B23 as a molecular target of ARF.
- Investigated ARF's interaction with B23 to understand growth inhibition.
- Examined ARF's role in both the MDM2-p53 pathway and ribosomal biogenesis.
Main Results:
- ARF targets the nucleolar protein B23 to execute its growth inhibitory function.
- ARF blocks cell cycle progression via the MDM2-p53 pathway.
- ARF suppresses ribosomal biogenesis through its interaction with B23.
Conclusions:
- ARF coordinates the inhibition of cell growth and proliferation.
- ARF's dual targeting of cell cycle machinery (MDM2-p53) and ribosomal biogenesis (B23) highlights its central role in growth control.
- Further research into ARF's nucleolar functions is warranted.
More Related Videos
09:38Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
Published on: June 26, 2019
06:44Bioluminescence Resonance Energy Transfer (BRET)-Based Assay for Measuring Interactions of CRAF with 14-3-3 Proteins in Live Cells
Published on: March 1, 2024
Related Concept Videos
Mitogens and the Cell Cycle
Abnormal Proliferation
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...